Energizing eggs with a patient's own mitochondria offers no benefit in assisted reproduction

July 3, 2018, European Society of Human Reproduction and Embryology

A controversial technique of energising eggs to improve their quality in assisted reproduction has been shown in an experimental randomised trial to offer no benefit in terms of pregnancy or live birth rate. The study was performed at a large centre in Spain in 59 infertile patients aged 42 or less with a past record of unsuccessful IVF and now having embryo screening in a subsequent attempt; the patients were described as "difficult to treat", and thus representing those previously proposed as likely to benefit from the enhanced egg quality procedure.

The technique, which has attracted much (albeit controversial) publicity in the past few years, requires the micro-injection of isolated mitochondria resident in "egg precursor cells" (found in ovarian tissue) into the egg of the infertile patient with a partner sperm during the ICSI procedure. The technology, now a proprietary process since 2014, has been claimed in previous reports to improve egg and embryo quality and increase the success rate of ICSI.

Results of the study are presented today by Dr. Elena Labarta of the IVI clinic in Valencia, Spain, at the 34th Annual Meeting of ESHRE in Barcelona. The study was performed at the IVI clinic in Valencia, now one of the world's largest fertility centres.

The study followed the protocol suggested in the proprietary procedure. A biopsy of ovarian tissue was performed in each patient to isolate any egg precursor cells to obtain their mitochondria. Sibling eggs retrieved after stimulation in each patient were then randomised to two groups: one to receive the egg precursor cell mitochondria during ICSI, and the other to act as a control with ICSI alone. Following ICSI and fertilisation, the eggs were cultured to the blastocyst stage, when a biopsy was performed for embryo screening before transfer. Almost half the full patient group did not reach this point, mainly because of development failure during culture (and mainly in the treatment group).

Results showed that live birth rate per blastocyst transfer was 41% in the mitochondria transfer group and 39% in the control group, an indication that any "energising" effect of the mitochondria made no difference to outcome. It was also found that the number of chromosomally normal (euploid) blastocysts in the mitochondria groups was significantly less than in the control group. Labarta said that IVI has now abandoned the procedure as a study subject.

The science behind the procedure has been dogged by controversy since first reported in mice more than a decade ago. Later, in 2012, the US biologist Jonathan Tilly described the discovery of human egg-producing stem cells, dubbed "bona fide" egg precursor cells, harvested from the ovaries of six young women, which the investigators were confident would go on to make "baby-making eggs". The controversy, of course, was implicit in the biology—that eggs could now be grown from egg precursor stem cells and need not be drawn only from a fixed store which declines to zero at the menopause.

At the level of fertility treatment the belief was that these egg precursor stem cells would invigorate eggs with a patient's own mitochondria. As the proprietary website says: the "treatment uses the energy-producing mitochondria from your own egg precursor . . . cells, which are immature egg cells found in the protective lining of your ovaries, to supplement the existing mitochondria in your eggs. This process is designed to boost your eggs' energy levels for embryo development."

Results of this randomised trial now suggest that this does not happen, with no differences found in live birth rates in either of the two embryo cohorts.

Labarta described the procedure as "an invasive technique" proposed for with a poor prognosis for success in ICSI. "Unfortunately," she said, "the technique was not found useful for this type of patient, so we see no value for this patient population."

On previous studies which did show a benefit she explained that they did not include a well defined control group. "Our study, however, was the first prospective trial with an intra-patient comparison which could evaluate the net impact of the technique in the quality of the , as they all came from the same cohort," said Labarta.

So do egg precursor cells really exist? Did the IVI trial identify and isolate mitochondria from these ovarian stem cells? Unfortunately, this study cannot provide the answer. "The isolation of egg precursor cells and mitochondrial extraction were processes performed by the external company," explained Labarta. "Our embryologists received the mitochondrial solution and injected it with the sperm at the time of ICSI. Thus, our team could never see the egg , but worked with a solution presumably containing the isolated from them."

So not yet time, it seems, to rewrite biology. Nor yet to define with certainty any method which can actually improve egg quality.

Explore further: A commonly offered add-on treatment for IVF fails to provide any benefit in a large randomized trial

More information: Abstract O-210, Tuesday 3 July 2018 - Autologous mitochondrial transfer as a complementary technique to ICSI to improve oocyte and embryo quality in IVF patients. A randomized pilot study.

Related Stories

A commonly offered add-on treatment for IVF fails to provide any benefit in a large randomized trial

July 3, 2018
An add-on treatment commonly offered to female IVF patients to improve their chance of success has been shown in a large randomised trial to be of no value. "Endometrial scratch", a technique whereby a small scratch or tissue ...

More than 8 million babies born from IVF since the world's first in 1978

July 3, 2018
Forty years after the birth of Louise Brown, the world's first test-tube baby, an international committee monitoring progress in assisted reproduction reports today that the global total of babies born as a result of IVF ...

Sub-fertility in men treated with ICSI associated with an increased risk of prostate cancer

July 3, 2018
Subfertile men who have received fertility treatment with the microinjection technique of ICSI (intracytoplasmic sperm injection) have been found at a significantly greater risk of prostrate cancer, according to an analysis ...

Spain now sets the pace of assisted reproduction in Europe with more than 100,000 treatments a year

July 4, 2017
Spain is Europe's most active country in assisted reproduction. ESHRE has collected the national registry data of ART cycles performed in Europe since 1997 and for its latest report (for 2014) found that a record 109,275 ...

Study examines if timing of IVF to avoid weekend procedures affects pregnancy success

October 25, 2017
It's unclear whether there is a need to retrieve a woman's eggs on weekends, in connection with in vitro fertilization/intracytoplasmatic sperm injection (IVF/ICSI) treatment in couples wishing to conceive. In a recent Acta ...

Mom's, not dad's, mitochondria create healthy embryos

August 29, 2017
Mammal embryos shed paternal mitochondria within days of fertilization, perhaps to ensure the offspring a healthy life, a new study shows. Researchers from the California Institute of Technology will present their findings ...

Recommended for you

RNAi therapy mitigates preeclampsia symptoms

November 19, 2018
A collaboration of scientists from the University of Massachusetts Medical School, Beth Israel Deaconess Medical Center and Western Sydney University, have shown that an innovative new type of therapy using small interfering ...

New blood test detects early stage ovarian cancer

November 19, 2018
Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer—a disease which kills over 1000 Australian women and 150,000 globally each ...

Human Cell Atlas study reveals maternal immune system modifications in early pregnancy

November 14, 2018
The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta. Researchers from the Wellcome Sanger Institute, Newcastle ...

Soy formula feeding during infancy associated with severe menstrual pain in adulthood

November 9, 2018
New research suggests that infant girls fed soy formula are more likely to develop severe menstrual pain as young adults. The finding adds to the growing body of literature that suggests exposure to soy formula during early ...

A major role for a small organ in the immune response during pregnancy

November 9, 2018
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden. This study, published in the Journal of Allergy ...

Mailed HPV tests can help find women at-risk for cervical cancer, study finds

November 7, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.